HLB Pharmaceutical Co., Ltd. manufactures pharmaceuticals and related products based on biotechnology. The company operates through the following business divisions: Pharmaceuticals, Biotechnology and Green Chemistry. Its products include peptide and antiviral drugs, ionic liquids and zanamivir derivatives. The company was founded on April 23, 1998 and is headquartered in Namyangju, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company